AIToday
AI in HealthcareAI Business & IndustryCrunchbase News AIPublished: Nov 6, 2026, 04:00 JST

Siggy raises $6 million to track mental health patients between visits

Send on LINE
Siggy raises $6 million to track mental health patients between visits

3 Key Points

  1. What happened

    Siggy raised $6 million in pre-seed funding led by Village Global, with backers including Albert Wenger, Immad Akhund and Toyin Ajayi, to hire clinicians and engineers and develop its software.

  2. Why it matters

    The startup says therapists and prescribers often work separately, leaving little time to discuss symptom or medication changes, so it uses AI check-ins and a daily 100-point Siggy Score to flag issues for clinicians between visits.

WHO IT HITSMental health clinicians and prescribers who treat patients in separate visits may get a richer picture of how patients are doing between appointments, while patients who see a therapist and a prescriber separately may see earlier flags on symptom or medication changes.

Not sure about something? Ask the AI

Questions and answers are published on this page.

Summaries like this, every morning.

Context & Analysis

Siggy is the second act for two founders who previously built businesses that deliver treatment outside a traditional doctor's office. Sabbagh co-founded Journey Clinical, which supports practices offering ketamine-assisted psychotherapy, and Engesæth co-founded Nurx, which he said grew to more than 2 million patients and an annual revenue run rate exceeding $100 million before merging with Thirty Madison in 2022. The two had considered starting a company together for years.

The gap Siggy targets is a structural one in mental healthcare: therapists and the clinicians prescribing medication often work separately, so a patient may see a therapist weekly but a prescriber only briefly every few months. Siggy's answer is to keep a conversation going between visits and compress it into a daily score, which the software flags for a clinician to review when it changes. Patients can continue seeing their existing therapists while using Siggy, and a planned feature would let them share information with other providers and involve loved ones in their care.

Investors pointed to both the founders' track record and the insurance-based model. Village Global's Amrit Rao said pairing the vision with insurance makes the ambition about access as much as technology, and Immad Akhund, a repeat backer of both founders, cited the longer-term aim of using AI to detect changes in brain health early. The company recently began accepting paying patients ahead of its public launch.

FAQ
How does Siggy collect information about patients?
Patients answer questions about their history through a free AI conversation, then meet a licensed clinician by video. Between appointments, they can talk with the AI and check in daily on sleep, mood, medication and physical feelings, optionally adding data from wearables such as Whoop, Oura or Apple Watch.
Does Siggy take insurance?
Siggy accepts commercial insurance in all 50 states and is expanding into government insurance programs. Patients can also pay directly, and the founders say the service will be permanently free to veterans.
Does Siggy prescribe controlled substances or handle crises?
No. The founders said Siggy does not prescribe controlled substances and is not a crisis service. Clinicians decide whether to continue treatment or adjust medication and handle all medical questions.
Crunchbase News AIRead Original Article
Send on LINE

AI news that matters for your work, delivered every morning.

Pick your industry and the AI tools you use, and get news related to your work every day.

Free · 30 seconds with Google · unsubscribe anytimeWhat is AIToday? →

Ask AI

Ask AI anything about this article. The AI reads this article, earlier AIToday articles, and Wikipedia, and cites its sources. Q&As are published on this page for other readers too.

Questions and answers are published on this page.

Related Articles

Next articleSemiAnalysis' GDPx puts AI agents to work; Claude Opus 5.5 leads at 12 percent